πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11802292

Modified orthopoxvirus vectors

TURNSTONE BIOLOGICS CORP. Β· Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11788077

Polynucleotides encoding optimized engineered meganucleases having specificity for a recog

Precision BioSciences, Inc. Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11786591

Recombinant metapneumovirus F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11786589

Human rotavirus strains and vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11787799

Potent antiviral pyrazolopyridine compounds

The Regents of the University of California Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11779660

Viral vectors for cancer therapy

Krystal Biotech, Inc. Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11780885

Zika viral antigen constructs

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11779570

Method for inhibiting dengue virus infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11781101

3D-printed models of biological microenvironments

Regents of the University of Minnesota Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11773143

Conformational epitopes in respiratory syncytial virus G protein central conserved region

The Regents of the University of California Β· Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11766489

Adeno-associated virus variant capsids and use for inhibiting angiogenesis

4D MOLECULAR THERAPEUTICS INC. Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11767303

Compounds and methods for inhibiting viral replication and methods of treating and prevent

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Sep 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11760755

Hepatitis B antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11761003

Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof

EYE INSTITUTE OF SHANDONG FIRST MEDICAL UNIVERSITY Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11759513

Human rotavirus G9P[6] strain and use as a vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 19 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11752214

Protein-antiviral compound conjugates

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11753627

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744831

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infec

United States Government as represented by the Department of Veterans Affairs Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11744887

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS, INC. Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11746335

Development of dengue virus vaccine components

The Government of the United States of American, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11738019

Substituted heterocycles as antiviral agents

Enanta Pharmaceuticals, Inc. Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730723

Compounds and methods for treating viral infections

LEXICON PHARMACEUTICALS, INC. Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11730801

Live attenuated Zika virus with 3'UTR deletion, vaccine containing and use thereof

The Board of Regents of the University of Texas System Β· Granted Tue Aug 22 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11718647

Virus-like particles and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted